VSEL stem cell therapy (Caladrius Biosciences)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVSEL stem cell therapy (Caladrius Biosciences)
Drug Alias NameVSEL stem cells (NeoStem)very small embryonic-like stem cells (NeoStem)VSEL stem cells (NeoStem)VSELS
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionBone modulators
TargetsUpdating
Therapy Area/IndicationsFractures, BoneWounds and InjuriesScleroderma, Systemic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLisata Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLisata Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsFractures, BoneWounds and InjuriesScleroderma, Systemic +[6] 

Other Information

ATC CodeN/A
Related LinksN/A